Golimumab
Measuring Golimumab drug concentrations in patients being treated with Golimumab for chronic autoimmune and inflammatory conditions
Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Golimumab allows for reliable measurement of Golimumab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Golimumab immediately before the next administration.
About Using Reagent
-
Sample Types
Whole blood, Serum, Plasma -
Reaction Time
10 mins -
Detection Range
0.20-30 μg/mL -
Intended Use
Quantitative determination of free Golimumab in human whole blood/serum/plasma
In Your Medical Field
AFIAS Golimumab measures Golimumab drug levels in patients' blood, using whole blood, serum, or plasma samples. This allows clinicians to obtain TDM results within just 10 minutes. It provides valuable insights into patients’ response to the treatment of Golimumab.